× Nephrotic syndrome; is rituximab the light at the end of the tunnel in the treatment of adult steroid-dependent minimal change disease and focal segmental glomerulosclerosis?

× An old disease, a new diagnosis; A 49 year-old man with nephrotic syndrome

× MPO-ANCA-associated necrotizing glomerulonephritis in rheumatoid arthritis; a case report and review of literature

× Rituximab and hypogammaglobulinemia in the setting of ABO-incompatible kidney transplantation

× Is it the time to offer rituximab as a cost-benefit treatment for immunoglobulin A nephropathy? A short-review to current concepts

× Mixed cryoglobulinemic glomerulonephritis and vasculitis in primary Sjögren’s syndrome

× Case series of low dose rituximab for membranous nephropathy; a single centre experience